ALK-Abelló A/S (ALK-B.CO)
246.80 DKK +0.65%
ALK-Abelló A/S rose 0.65% in the latest session, at 246.80 DKK. By market cap it is number 5 of the 9 health care stocks on the C25 heatmap. Its trailing P/E of 40.5 is above the median of those peers (31.9). The price is 9.1% below its 52-week high.
Key numbers
- Price
- 246.80 DKK
- Day change
- +0.65% (1.60)
- Market cap
- 54.7B DKK
- P/E (trailing)
- 40.5
- P/E (forward)
- 33.7
- Dividend yield
- 0.65%
- 50-day average
- 215.11
- 200-day average
- 226.59
- 52-week range
- 191.80 – 271.40
- Next earnings
- 17 Nov 2026
- Dividend per share (annual)
- 1.60 DKK
Data as of 3 Nov 2026, 16:59 CET. Market data may be delayed.
ALK-Abelló A/S over the past year
From daily closing prices. The highest close in the period was 270.40 DKK on 12 Jun 2026, the lowest 192.30 DKK on 15 Sept 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +22.42% | +13.11% | -3.74% | +7.96% | +18.43% |
| Month | Close (DKK) | Change |
|---|---|---|
| November 2026 | 246.80 | -0.48% |
| October 2026 | 248.00 | +25.00% |
| September 2026 | 198.40 | -4.98% |
| August 2026 | 208.80 | -5.95% |
| July 2026 | 222.00 | -9.09% |
| June 2026 | 244.20 | -8.88% |
| May 2026 | 268.00 | +12.42% |
| April 2026 | 238.40 | +17.90% |
| March 2026 | 202.20 | -8.26% |
| February 2026 | 220.40 | +6.17% |
| January 2026 | 207.60 | -9.19% |
| December 2025 | 228.60 | -0.95% |
Health care peers
ALK-Abelló A/S is on the C25 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Novo Nordisk A/S NOVO-B.CO | -0.02% | 1.19T DKK | 10.3 |
| Genmab A/S GMAB.CO | +0.57% | 229B DKK | 45.9 |
| Coloplast A/S COLO-B.CO | +2.97% | 112B DKK | 36.3 |
| Demant A/S DEMANT.CO | -0.97% | 77.1B DKK | 31.9 |
| ALK-Abelló A/S ALK-B.CO | +0.65% | 54.7B DKK | 40.5 |
| Ambu A/S AMBU-B.CO | +0.86% | 21.5B DKK | 42.9 |
| Bavarian Nordic A/S BAVA.CO | -2.71% | 18.2B DKK | 12.5 |
| GN Store Nord A/S GN.CO | +0.71% | 15.6B DKK | — |
| Zealand Pharma A/S ZEAL.CO | +1.17% | 15.5B DKK | 6.1 |
More on ALK-B
Open ALK-B.CO in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.